World Federation of Hemophilia Guidelines for the Management of Hemophilia, 3rd edition
- MeSH Terms
- Hemophilia B (C16.320.322.235); Hemophilia B (C16.320.099.510); Hemophilia B (C15.378.463.510); Hemophilia B (C15.378.100.141.510); Hemophilia B (C15.378.100.100.510); Hemophilia A (C16.320.099.500); Hemophilia A (C15.378.463.500); Hemophilia A (C15.378.100.141.500); Hemophilia A (C15.378.100.100.500); Factor XIII Deficiency (C15.378.100.100.335);von Willebrand Diseases (C15.378.100.100.900);Blood Coagulation Disorders; Inherited (C15.378.100.100)
- Guideline Contact
- TreatmentGuidelines@WFH.org
- Date for Review
- n/a
- Publication Date
- 03/08/2020
- Date of Last Evidence Search
- 19-Nov
- Methods Applied
- Evidence-based & Trustworthy Consensus-Based Statement (TCBS); confidence in the panel composition and screening; systematic and comprehensive evidence searches; formal consensus achievement; transparency of data and methods throughout; rigorous review process.
- Publication Scope
- assessment
- diagnosis
- management
- treatment
- Countries of Application
- Canada
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- World Federation of Hemophilia
- Willingness to Collaborate
- Yes
- Publication Year
- 2020